Medical Xpress February 10, 2025
Gordy Slack, Stanford University

Sepsis, a life-threatening organ dysfunction, is responsible for an estimated 1 in 5 deaths globally and 1 in 3 deaths that occur within a U.S. hospital. It happens due to a dysregulated immune response to infection, and its high mortality rate correlates to the difficulty in quickly diagnosing and appropriately addressing the origin of infection, be it bacterial, viral, or some other pathogen. Current methods can delay that life-or-death determination for as long as three days.

Enter the Stanford Medicine lab of Purvesh Khatri, where a test developed to reduce that time frame to roughly 30 minutes—an advancement that could be transformative for millions of patients each year—was cleared by the Food and Drug Administration in January.

Khatri, Ph.D., a...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Health System / Hospital, Provider
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
HHS Explores Stronger FDA Oversight for Food Ingredients
HHS Secretary Kennedy Directs FDA to Explore Rulemaking to Eliminate Self-Affirmed GRAS Pathway

Share This Article